Biocon Biologics eyes $200M, plans IPO in 2 years: Kiran Mazumdar-Shaw

With the funding, Biocon is looking to fund its research and development, and infuse capital to expand its biosimilars business

from technology - Technology News | Latest Technology & Startups Industry Information and Updates: ET Tech : ETtech.com https://ift.tt/37uXTvM

Post a Comment

0 Comments